Looking forward to the K, but looking forward more to the Q1. Revs for Q1 should be higher than all of last year as most of the Attrius sales actually got placed in Q1, with some from last year dribbling into Q2. 70% of the cost of purchase comes from delivery (60%) and the remaining 10% after first successful use. Q1 2011 should be the highest quarter in company history and should also exceed all sales for all prior years reported in any 10K thus far, including the 10K for 2010 coming up. The 10K for 2010 will help show the direction of revs, and the 10Q for Q1, 2011 will show a dramatic increase in revs moving forward. Some of the late sales of the Attrius the end of 2010 will show up in Q2 and added to that will be pharma Indium sales, which will also boost revs showing up in Q2, as well as PosiRx sales recorded in Q2. Q3 moves us into a better part of the year for selling the high ticket Attrius. Pharma and PosiRx sales should really be ramping up then also. It continues to build from there.
JJ
News 
Market Data 
Discover 
AI
